EPX-100(盐酸克立咪唑)作为 Lennox Gastaut 综合征患儿的辅助治疗
EPX-100(盐酸克立咪唑)作为 Lennox-Gastaut 综合征患儿辅助治疗的 20 周多中心、随机、双盲、安慰剂对照、概念验证试验
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in children and adult participants with Lennox-Gastaut syndrome (LGS).
研究概览
详细说明
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCl as adjunctive therapy in children and adult participants with LGS.
The study will consist of an Observational Period, a Double-Blind (DB) Period, and an optional Open-Label Extension (OLE) Period.
研究类型
注册 (估计的)
阶段
- 第三阶段
联系人和位置
学习联系方式
- 姓名:Juby Philip
- 电话号码:(302) 559-4320
- 邮箱:clinicaltrials@harmonybiosciences.com
研究联系人备份
- 姓名:Cindy Sandy
- 电话号码:(317) 258-7262
- 邮箱:clinicaltrials@harmonybiosciences.com
学习地点
-
-
-
Beijing、中国、100045
- 招聘中
- Beijing Children's Hospital, Capital Medical University - PIN
-
首席研究员:
- Hui Xiong
-
Beijing、中国、100034
- 招聘中
- Peking University First Hospital - Changqiao Campus
-
首席研究员:
- Yuwu Jiang
-
Beijing、中国、100034
- 招聘中
- Peking University First Hospital - Daxing Campus
-
首席研究员:
- Yuwu Jiang
-
Changchun、中国、130021
- 招聘中
- The First Hospital of Jilin University
-
首席研究员:
- Jianmin Liang
-
Changsha、中国、410007
- 招聘中
- Hunan Children's Hospital
-
首席研究员:
- Sai Yang
-
Chengdu、中国、610041
- 招聘中
- West China Second University Hospital, Sichuan University - Huaxi Campus
-
首席研究员:
- Rong Luo
-
Chengdu、中国、610073
- 招聘中
- Chengdu Women's and Children's Central Hospital
-
首席研究员:
- Li Yan
-
Chongqing、中国、400014
- 招聘中
- Children's Hospital of Chongqing Medical University
-
首席研究员:
- Li Jiang
-
Guangzhou、中国、510260
- 招聘中
- The Second Affiliated Hospital of Guangzhou Medical University
-
首席研究员:
- Xiaorong Liu
-
Guiyang、中国、550004
- 招聘中
- The Affiliated Hospital of Guizhou Medical University
-
首席研究员:
- Rong Ai
-
Jinan、中国、250012
- 招聘中
- Qilu Hospital of Shandong University
-
首席研究员:
- Baomin Li
-
Nanchang、中国、330006
- 招聘中
- Jiangxi Provincial Children's Hospital
-
首席研究员:
- Yong Chen
-
Shenzhen、中国、518000
- 招聘中
- Shenzhen Children's Hospital
-
首席研究员:
- Dezhi Cao
-
Wuhan、中国、430015
- 招聘中
- Wuhan Children's Hospital
-
首席研究员:
- Dan Sun
-
Xi'an、中国、710004
- 招聘中
- The Second Affiliated Hospital of Xi'an Jiaotong University
-
首席研究员:
- Lin Yang
-
Xuzhou、中国、221006
- 招聘中
- Xuzhou Children's Hospital
-
首席研究员:
- Xiaoming Liu
-
-
Hunan
-
Changsha、Hunan、中国、410008
- 招聘中
- Xiangya Hospital Central South University
-
首席研究员:
- Jing Peng
-
-
Shanghai Municipality
-
Shanghai、Shanghai Municipality、中国、200062
- 招聘中
- Children's Hospital of Shanghai
-
首席研究员:
- Simei Wang
-
-
-
-
Hajdú-Bihar
-
Debrecen、Hajdú-Bihar、匈牙利、4032
- 招聘中
- Debreceni Egyetem Klinikai Kozpont Nagyerdei Campus
-
首席研究员:
- Monika Bessenyei
-
-
-
-
Andhra Pradesh
-
Hyderabad、Andhra Pradesh、印度、500082
- 招聘中
- Nizams Institute of Medical Sciences
-
首席研究员:
- Surya Prabha Turaga
-
Hyderabad、Andhra Pradesh、印度、500081
- 招聘中
- Yashoda Hospitals Hitec City
-
首席研究员:
- Lokesh Lingappa
-
-
Gujarat
-
Ahmedabad、Gujarat、印度、380054
- 招聘中
- Royal Institute of Child Neurosciences
-
首席研究员:
- Nitish Vora
-
Surat、Gujarat、印度、395002
- 招聘中
- Saachi Children Hospital
-
首席研究员:
- Ritesh Shah
-
-
Kerala
-
Calicut、Kerala、印度、673016
- 招聘中
- Aster Malabar Institute of Medical Sciences Ltd
-
首席研究员:
- Smilu Mohanlal
-
-
-
-
-
Ortahisar、土耳其(türkiye)、61080
- 招聘中
- Karadeniz Teknik Universitesi Farabi Hastanesi
-
首席研究员:
- Ali Cansu
-
-
Eskişehir
-
Odunpazari、Eskişehir、土耳其(türkiye)、26040
- 招聘中
- Eskisehir Osmangazi Universitesi Saglik Uygulama ve Arastirma Hastanesi
-
首席研究员:
- Kursat Carman
-
-
-
-
-
Belgrade、塞尔维亚、11000
- 招聘中
- Mother and Child Health Care Institute of Serbia Dr Vukan Cupic
-
首席研究员:
- Biljana Vucetic Tadic
-
Belgrade、塞尔维亚、11000
- 招聘中
- Childrens University Hospital
-
首席研究员:
- Dimitrije Nikolic
-
Niš、塞尔维亚、18 000
- 招聘中
- University Clinical Center Nis
-
首席研究员:
- Tatjana Tosic
-
Novi Sad、塞尔维亚、21000
- 招聘中
- Children and Youth Health Care Institute of Vojvodina
-
首席研究员:
- Tatjana Redzek Mudrinic
-
-
-
-
-
Catanzaro、意大利、88100
- 招聘中
- Azienda Ospedaliera Universitaria Renato Dulbecco - AO Mater Domini
-
首席研究员:
- Antonio Gambardella
-
Florence、意大利、50139
- 招聘中
- Azienda Ospedaliero Universitaria A Meyer
-
首席研究员:
- Renzo Guerrini
-
Milan、意大利、20133
- 招聘中
- Fondazione IRCCS Istituto Neurologico Carlo Besta
-
首席研究员:
- Giuseppe Didato
-
Pavia、意大利、27100
- 招聘中
- Fondazione Istituto Neurologico Nazionale Casimiro Mondino IRCCS
-
首席研究员:
- Elena Tartara
-
-
Liguria
-
Genoa、Liguria、意大利、16147
- 招聘中
- IRCCS Istituto Giannina Gaslini
-
首席研究员:
- Maria Margherita Mancardi
-
Genoa、Liguria、意大利、16132
- 招聘中
- IRCCS Azienda Ospedaliera Metropolitan
-
首席研究员:
- Flavio Villani
-
-
Molise
-
Pozzilli、Molise、意大利、86077
- 招聘中
- IRCCS Istituto Neurologico Mediterraneo Neuromed
-
首席研究员:
- Alfredo D'Aniello
-
-
-
-
Lesser Poland Voivodeship
-
Krakow、Lesser Poland Voivodeship、波兰、30-363
- 招聘中
- Centrum Medyczne Plejady Magdalena Celinska
-
首席研究员:
- Marta Zolnowska, MD
-
-
Lower Silesian Voivodeship
-
Wroclaw、Lower Silesian Voivodeship、波兰、50-414
- 招聘中
- Premium Clinic Wrocław Centrum Medyczne
-
首席研究员:
- Monika Sluzewska-Niedzwiedz
-
-
Masovian Voivodeship
-
Warsaw、Masovian Voivodeship、波兰、02-829
- 招聘中
- Neurosphera
-
首席研究员:
- Beata Zwolinska
-
-
-
-
-
Bucharest、罗马尼亚、050098
- 招聘中
- Emergency University Hospital
-
首席研究员:
- Ioana Raluca Mindruta
-
Bucharest、罗马尼亚、041408
- 招聘中
- Centrul National Clinic De Recuperare Neuropsihomotorie Copii Robanescu-Padure
-
首席研究员:
- Madalina Leanca
-
Iași、罗马尼亚、700309
- 招聘中
- Sf. Maria Children Emergency Clinical Hospital Iasi
-
首席研究员:
- Ioana Grigore
-
-
-
-
Arkansas
-
Little Rock、Arkansas、美国、72202
- 主动,不招人
- Arkansas Children's Hospital
-
-
California
-
Orange、California、美国、92868
- 主动,不招人
- UC Irvine Medical Center
-
-
Florida
-
Miami、Florida、美国、33136
- 招聘中
- University of Miami Miller School of Medicine
-
接触:
- Brett Alonso Cardenas
- 电话号码:305-243-3100
- 邮箱:bac301@med.miami.edu
-
首席研究员:
- Kamil Detyniecki, MD
-
Orlando、Florida、美国、32804
- 招聘中
- AdventHealth Innovation Tower
-
首席研究员:
- Holly Skinner, DO
-
Orlando、Florida、美国、34746
- 暂停
- Rare Disease Research
-
Winter Park、Florida、美国、32789
- 主动,不招人
- Pediatric Neurology and Epilepsy Specialists
-
-
Illinois
-
Chicago、Illinois、美国、60611
- 招聘中
- Re:Cognition Health
-
接触:
- Antonio Iglesias, MD
- 电话号码:312-971-3318
- 邮箱:aiglesias@re-cognitionhealth.com
-
首席研究员:
- Antonio Iglesias, MD
-
-
Kentucky
-
Louisville、Kentucky、美国、40202
- 招聘中
- Norton Children's Medical Center
-
首席研究员:
- Jaime Shoup, MD
-
接触:
- Madeline McGinty-Holmes
- 电话号码:502-629-5568
- 邮箱:madeline.mcginty-holmes@louisville.edu
-
-
Michigan
-
Detroit、Michigan、美国、48202
- 主动,不招人
- Henry Ford Hospital
-
-
Minnesota
-
Roseville、Minnesota、美国、55102
- 招聘中
- Minnesota Epilepsy Group, P.A.
-
接触:
- Sarah Ellis, MD
- 电话号码:651-377-8319
- 邮箱:sellis@mnepilepsy.net
-
首席研究员:
- Stephanie Ahrens, MD
-
-
Nebraska
-
Omaha、Nebraska、美国、68114
- 招聘中
- Children's Nebraska
-
接触:
- Sookyong Koh, MD, PhD
- 电话号码:773-929-4445
- 邮箱:skoh@childrensnebraska.org
-
首席研究员:
- Sookyong Koh
-
-
New Jersey
-
Marlboro、New Jersey、美国、07746
- 招聘中
- Tekton Research
-
首席研究员:
- Amor Mehta, MD
-
接触:
- Aimee Kinlan
- 电话号码:626-218-8294
- 邮箱:aimee.kinlan@tektonresearch.com
-
-
New York
-
New York、New York、美国、10021
- 招聘中
- Weill Cornell Medicine/New York Presbyterian Hospital
-
接触:
- Lundy Santil
- 电话号码:Ext. 198 800-785-3150
- 邮箱:ludny.saintil@thermofisher.com
-
接触:
- Asim Shahid
- 邮箱:los9075@med.cornell.edu
-
首席研究员:
- Asim Shahid, MD
-
New York、New York、美国、10016-4852
- 招聘中
- NYU Comprehensive Epilepsy Center - BRANY - PPDS
-
首席研究员:
- Dana Price
-
-
North Carolina
-
Charlotte、North Carolina、美国、28211
- 招聘中
- On-Site Clinical Solution
-
首席研究员:
- Robert Nahouraii
-
接触:
- Ludny Saintil
- 电话号码:198 800-785-3150
- 邮箱:ludny.santil@thermofischer.com
-
Charlotte、North Carolina、美国、28207
- 招聘中
- Atrium Health STRIVE Research
-
接触:
- Jessica Lindley
- 邮箱:Jessica.Lindley@atriumhealth.org
-
首席研究员:
- Ravi Singh, MD
-
Durham、North Carolina、美国、27705
- 招聘中
- Duke University Medical Center
-
接触:
- Muhammad Zafar, MD
- 邮箱:muhammad.zafar@duke.edu
-
首席研究员:
- Muhammad Zafar, MD
-
Morrisville、North Carolina、美国、27560
- 招聘中
- PPD Virtual-Science 37, Inc.
-
首席研究员:
- Antonio Iglesias, MD
-
接触:
- Victoria Taylor
- 电话号码:615-707-9148
- 邮箱:victoria.taylor@science37.com
-
-
Pennsylvania
-
Philadelphia、Pennsylvania、美国、19104
- 招聘中
- Children's Hospital of Philadelphia
-
首席研究员:
- Eric Marsh, MD
-
-
Texas
-
Dallas、Texas、美国、75235
- 招聘中
- Children's Health Specialty Center
-
首席研究员:
- Charuta Joshi
-
Houston、Texas、美国、77030
- 招聘中
- UTHealth Houston
-
接触:
- Antoinette Bernal-Tent
- 电话号码:713-500-7105
- 邮箱:Antoinette.BernalTent@uth.tmc.edu
-
首席研究员:
- Mary Koenig, MD
-
-
Utah
-
Salt Lake City、Utah、美国、84132
- 招聘中
- Clinical Neurosciences Center
-
首席研究员:
- Angela Peters, MD
-
-
-
-
-
Barcelona、西班牙、08025
- 招聘中
- Hospital de La Santa Creu i Sant Pau
-
首席研究员:
- Alba Sierra-Marcos
-
Barcelona、西班牙、08035
- 招聘中
- Hospital Universitario Vall d'Hebron - PPDS
-
首席研究员:
- Manuel Toledo Argany
-
Madrid、西班牙、28009
- 招聘中
- Hospital Infantil Universitario Niño Jesus - PIN
-
首席研究员:
- Victor Soto Insuga
-
Málaga、西班牙、29010
- 招聘中
- Hospital Regional Universitario de Malaga - Hospital General
-
首席研究员:
- Pedro Serrano
-
Pamplona、西班牙、31008
- 招聘中
- Hospital Universitario de Navarra
-
首席研究员:
- Sergio Aguilera Albesa
-
Seville、西班牙、41013
- 招聘中
- Centro de Neurologia Avanzada
-
首席研究员:
- Juan Jesús Rodríguez Uranga, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Key Inclusion Criteria:
-
Males or females, ages ≥2 to ≤55 years, at the time of Screening.
-
Participant/parent/legal authorized representative (LAR) willing and able to give written informed consent/assent.
-
Diagnosis of LGS, including:
- Evidence of at least one type of countable major motor seizure.
- History of electroencephalogram (EEG) consistent with LGS (abnormal background activity, and one of the following: 1) slow spike-wave discharges [<2.5 Hz], or 2) paroxysmal fast activity during sleep).
- Abnormal cognitive development.
- Onset of seizures at 11 years of age or younger.
Key Exclusion Criteria:
- Known sensitivity, allergy, or previous exposure to clemizole HCl.
- Known history of long QT syndrome or any significant history of a serious abnormality of the electrocardiogram (ECG) (e.g., recent myocardial infarction, clinically significant arrhythmia).
- Family history of sudden cardiac death, unexplained death, or death from a primary dysrhythmia potentially associated with QT prolongation in any family member.
- Seizures secondary to illicit drug or alcohol use, infection, neoplasm, demyelinating disease, degenerative neurological disease, or progressive central nervous system disease, metabolic illness, recent anoxic episode within the last 6 months requiring resuscitation, or progressive degenerative disease or any other condition, which in the opinion of the investigator, could affect seizure control.
- Epilepsy surgery planned during the study or epilepsy surgery within 6 months prior to Screening.
- Concomitant use of fenfluramine.
- Prior or concomitant use of lorcaserin.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
安慰剂比较:Placebo
Participants will receive their first dose of study drug following randomization. |
Placebo will be administered as an oral solution. |
|
实验性的:Double-blind clemizole HCl
Participants will receive their first dose of study drug following randomization. |
Clemizole HCl will be administered as an oral solution.
其他名称:
|
|
实验性的:Open-label clemizole HCl
Eligible participants who complete the DB Period will have the option to continue in the OLE Period, during which they will receive clemizole HCl for up to 3 years. |
Clemizole HCl will be administered as an oral solution.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Percent Change in CMMS-28
大体时间:From Baseline Period up to 16 weeks
|
Percent change in CMMS-28 from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Proportion of Participants with ≥50% Reduction in CMMS-28
大体时间:From Baseline Period up to 16 weeks
|
Proportion of participants with ≥50% reduction in CMMS-28 from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Percent Change in CMMS-28 Seizure-free Days
大体时间:From Baseline Period up to 16 weeks
|
Percent change in CMMS-28 seizure-free days from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Clinical Global Impression of Change (CGI-C) Score
大体时间:Week 16
|
CGI-C score at the end of the DB Period |
Week 16
|
|
Caregiver Global Impression of Change (CaGI-C) Score
大体时间:Week 16
|
CaGI-C score at the end of the DB Period |
Week 16
|
|
Caregiver Global Impression of Change in Seizure Intensity/Duration (CaGI-CSID) Score
大体时间:Week 16
|
CaGI-CSID score at the end of the DB Period |
Week 16
|
|
Change in Quality of Life Inventory (QI)-Disability Score
大体时间:From Baseline Period up to 16 weeks
|
Change in QI-disability score from Baseline to the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Percent Change per 28 Days in the Number of Seizure Free Days
大体时间:From Baseline Period up to 16 weeks
|
Percent change per 28 days in the number of seizure-free days (based on all seizure types) from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Percent Change in CMMS-28
大体时间:From Baseline Period up to 12 weeks
|
Percent change in CMMS-28 from the Baseline Period through the end of the DB Maintenance Phase only |
From Baseline Period up to 12 weeks
|
|
Proportion of Participants with ≥50% Reduction in CMMS-28
大体时间:From Baseline Period up to 12 weeks
|
Proportion of participants with ≥50% reduction in CMMS-28 from the Baseline Period through the end of the DB Maintenance Phase only |
From Baseline Period up to 12 weeks
|
|
Incidence of Treatment-Emergent Adverse Events (TEAEs)
大体时间:From the first dose administration of study drug up to end of the study, approximately up to 172 weeks
|
Incidence of TEAEs will be compared among the treatment groups |
From the first dose administration of study drug up to end of the study, approximately up to 172 weeks
|
合作者和调查者
赞助
调查人员
- 研究主任:Amit Ray, MD、Harmony Biosciences Management, Inc.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- EPX-100-003
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.